Summary
This article discusses the results of the multicenter, randomized, open-label, controlled, Phase 3 Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status study [CENTRIC; NCT00689221; J Clin Oncol 2013 (suppl; abstr LBA2009)].
- Oncology Clinical Trials
- Radiation Therapy
- Head & Neck Cancers
- Radiology
- Oncology Clinical Trials
- Radiation Therapy
- Oncology
- Head & Neck Cancers
- Radiology
- © 2013 MD Conference Express®
Tools
Table of contents
Cited By...
- No citing articles found.